BIO-UV Group S.A. (EPA:ALTUV)
France · Delayed Price · Currency is EUR 1.080
-0.010 (-0.92%)
Oct 2, 2026, 5:17 PM CET
BIO-UV Group Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 15 | 21 | 22 | 25 | 47 | 53 | |
Market Cap Growth | -34.33% | -8.60% | -9.34% | -47.45% | -11.04% | -23.85% |
Enterprise Value | 25 | 32 | 45 | 50 | 74 | 54 |
Last Close Price | 1.08 | 1.48 | 2.20 | 2.44 | 4.57 | 5.08 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 81.38 | 24.53 | 715.63 | 198.21 | 19.48 | 76.81 |
Forward PE | - | 3.21 | 3.21 | 5.65 | 9.46 | 18.30 |
PS Ratio | 0.39 | 0.56 | 0.58 | 0.59 | 0.92 | 1.50 |
PB Ratio | 0.36 | 0.51 | 0.69 | 0.77 | 1.46 | 1.73 |
P/TBV Ratio | 1.63 | 2.50 | 68.90 | - | 151.48 | - |
P/FCF Ratio | 8.41 | 6.86 | 4.52 | 5.79 | 98.95 | 92.62 |
P/OCF Ratio | 4.42 | 4.43 | 3.25 | 3.97 | 17.47 | 16.05 |
PEG Ratio | - | 0.33 | 0.33 | 0.58 | 0.07 | 0.07 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.68 | 0.88 | 1.15 | 1.19 | 1.44 | 1.53 |
EV/EBITDA Ratio | 18.03 | 14.61 | 16.59 | 19.30 | 16.10 | 39.23 |
EV/EBIT Ratio | 36.28 | 20.78 | 20.95 | 21.72 | 17.83 | 54.25 |
EV/FCF Ratio | 14.56 | 10.78 | 9.00 | 11.67 | 154.75 | 94.68 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.45 | 0.50 | 0.73 | 0.88 | 0.90 | 1.01 |
Debt / EBITDA Ratio | 13.13 | 9.16 | 8.92 | 10.93 | 6.37 | 22.37 |
Debt / FCF Ratio | 10.60 | 6.76 | 4.84 | 6.61 | 61.24 | 54.00 |
Net Debt / Equity Ratio | 0.26 | 0.25 | 0.62 | 0.79 | 0.84 | 0.66 |
Net Debt / EBITDA Ratio | 7.61 | 4.55 | 7.48 | 9.88 | 5.94 | 14.71 |
Net Debt / FCF Ratio | 6.14 | 3.36 | 4.05 | 5.97 | 57.08 | 35.51 |
Asset Turnover | 0.51 | 0.55 | 0.56 | 0.58 | 0.66 | 0.53 |
Inventory Turnover | 1.23 | 1.20 | 1.11 | 0.96 | 1.34 | 1.20 |
Quick Ratio | 1.23 | 1.20 | 1.12 | 0.99 | 0.93 | 1.07 |
Current Ratio | 2.21 | 2.15 | 2.64 | 2.57 | 2.53 | 1.85 |
Return on Equity (ROE) | 0.46% | 2.28% | 0.10% | 0.39% | 7.67% | 2.27% |
Return on Assets (ROA) | 0.60% | 1.43% | 1.94% | 1.97% | 3.33% | 0.94% |
Return on Invested Capital (ROIC) | 1.35% | 2.79% | 1.31% | 3.92% | 6.04% | 2.43% |
Return on Capital Employed (ROCE) | 1.20% | 2.80% | 3.70% | 3.80% | 6.70% | 1.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.28% | 4.08% | 0.14% | 0.51% | 5.13% | 1.30% |
FCF Yield | 11.89% | 14.58% | 22.11% | 17.28% | 1.01% | 1.08% |
Dividend Yield | - | - | - | - | 0.85% | - |
Payout Ratio | - | - | - | 486.08% | 20.90% | - |
Buyback Yield / Dilution | -17.07% | -33.08% | -0.44% | -2.44% | -0.21% | -18.05% |
Total Shareholder Return | -17.07% | -33.08% | -0.44% | -2.44% | 0.64% | -18.05% |